Literature DB >> 11290756

Cutting edge: evidence for a signaling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils.

R G Sitrin1, P M Pan, R A Blackwood, J Huang, H R Petty.   

Abstract

Leukocyte urokinase plasminogen activator receptors (uPARs) cluster at adhesion interfaces and at migratory fronts where they participate in adhesion, chemotaxis, and proteolysis. uPAR aggregation triggers activation signaling even though this glycolipid-anchored protein must associate with membrane-spanning proteins to access the cell interior. This study demonstrates a novel partnership between uPAR and L-selectin in human polymorphonuclear neutrophils. Fluorescence resonance energy transfer demonstrated a direct physical association between uPAR and L-selectin. To examine the role of L-selectin in uPAR-mediated signaling, uPAR was cross-linked and intracellular Ca(2+) concentrations were measured by spectrofluorometry. A mAb reactive against the carbohydrate binding domain (CBD) of L-selectin substantially inhibited uPAR-mediated Ca(2+) mobilization, whereas mAbs against the beta(2) integrin complement receptor 3 (CR3), another uPAR-binding adhesion protein, had no effect. Similarly, fucoidan, a sulfated polysaccharide that binds to L-selectin CBD, inhibited the Ca(2+) signal. We conclude that uPAR associates with the CBD region of L-selectin to form a functional signaling complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290756     DOI: 10.4049/jimmunol.166.8.4822

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Identification of nucleolin as a new L-selectin ligand.

Authors:  G Harms; R Kraft; G Grelle; B Volz; J Dernedde; R Tauber
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

Review 2.  Role of cell adhesion molecules in leukocyte recruitment in the liver and gut.

Authors:  A Ala; A P Dhillon; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2003-02       Impact factor: 1.925

3.  Ion channel clustering enhances weak electric field detection by neutrophils: apparent roles of SKF96365-sensitive cation channels and myeloperoxidase trafficking in cellular responses.

Authors:  Andrei L Kindzelskii; Howard R Petty
Journal:  Eur Biophys J       Date:  2005-07-26       Impact factor: 1.733

Review 4.  Interactions of integrins with their partner proteins in leukocyte membranes.

Authors:  Howard R Petty; Randall G Worth; Robert F Todd
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

5.  Association between urokinase haplotypes and outcome from infection-associated acute lung injury.

Authors:  John Arcaroli; Jeff Sankoff; Nianjun Liu; David B Allison; James Maloney; Edward Abraham
Journal:  Intensive Care Med       Date:  2007-11-10       Impact factor: 17.440

Review 6.  Serine proteases, inhibitors and receptors in renal fibrosis.

Authors:  Allison A Eddy
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

7.  Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins.

Authors:  Sha Zhu; Candece L Gladson; Kimberly E White; Qiang Ding; Jerry Stewart; Tong H Jin; Harold A Chapman; Mitchell A Olman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-01       Impact factor: 5.464

Review 8.  A head-to-tail view of L-selectin and its impact on neutrophil behaviour.

Authors:  Aleksandar Ivetic
Journal:  Cell Tissue Res       Date:  2018-01-20       Impact factor: 5.249

Review 9.  Molecular Targets and Related Biologic Activities of Fucoidan: A Review.

Authors:  Zhen Lin; Xiaohui Tan; Yu Zhang; Fangping Li; Ping Luo; Huazhong Liu
Journal:  Mar Drugs       Date:  2020-07-22       Impact factor: 5.118

Review 10.  Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.

Authors:  Daniela Alfano; Paola Franco; Maria Patrizia Stoppelli
Journal:  Front Cell Dev Biol       Date:  2022-04-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.